Nine Monthly Results Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
5,305.70
4,944.30
4,603.73
4,602.63
4,518.76
5,965.77
6,725.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,305.70
4,944.30
4,603.73
4,602.63
4,518.76
5,965.77
6,725.24
Raw Material Cost
1,401.30
1,324.00
1,224.06
990.25
998.15
1,927.86
2,496.19
Purchase of Finished goods
212.30
187.30
202.20
149.76
131.52
132.14
188.38
(Increase) / Decrease In Stocks
77.30
102.00
-78.10
-66.77
17.29
-173.95
-135.37
Employee Cost
1,677.30
1,661.00
1,631.72
1,533.02
1,447.03
1,490.09
1,429.20
Power Cost
0.00
0.00
0.00
0.00
0.00
265.26
353.45
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,109.20
1,040.60
1,066.82
1,087.39
902.92
1,010.90
1,012.35
Total Expenditure (Excl Depreciation)
4,477.40
4,314.90
4,046.70
3,693.65
3,496.91
4,652.30
5,344.20
Operating Profit (PBDIT) excl Other Income
828.30
629.40
557.03
908.98
1,021.85
1,313.47
1,381.04
Other Income
44.90
54.30
33.88
14.25
10.95
25.18
42.32
Operating Profit (PBDIT)
873.20
683.70
590.91
923.23
1,032.80
1,338.65
1,423.36
Interest
187.60
199.30
132.64
105.98
140.76
193.05
158.22
Exceptional Items
362.80
0.00
-56.82
0.00
-10.89
-32.94
-45.47
Gross Profit (PBDT)
1,048.40
484.40
401.45
817.25
881.15
1,112.66
1,219.67
Depreciation
273.40
280.90
282.80
281.15
262.71
303.07
275.88
Profit Before Tax
774.70
216.60
117.00
536.10
618.44
809.59
943.79
Tax
89.60
89.70
78.56
170.85
214.16
217.07
266.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
685.40
113.80
40.09
365.25
404.28
592.52
677.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
220.78
45.23
0.00
Net Profit
685.40
113.80
40.09
365.25
625.06
637.75
677.66
Share in Profit of Associates
-0.40
20.70
-4.46
-11.32
-3.10
0.00
0.00
Minority Interest
0.40
0.40
0.49
0.08
-0.19
0.00
9.45
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
685.80
135.70
36.86
354.39
621.97
637.75
673.75
Equity Capital
15.80
15.80
15.91
15.92
15.93
15.93
15.58
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
6.36
4.2
-0.98
3.2
19.46
12.77
16.74
Operating Profit Margin (Excl OI)
15.61%
12.73%
12.1%
19.75%
22.61%
22.02%
20.54%
Gross Profit Margin
19.76%
9.8%
8.72%
17.76%
19.5%
18.65%
18.14%
PAT Margin
12.92%
2.3%
0.87%
7.94%
8.95%
9.93%
10.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 7.31% vs 7.40% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 405.38% vs 268.15% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 31.60% vs 12.99% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -5.87% vs 50.26% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Jubilant Pharmo With
Figures in Rs cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
5,305.70
9,199.93
-3,894.23
-42.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,305.70
9,199.93
-3,894.23
-42.33%
Raw Material Cost
1,401.30
1,471.08
-69.78
-4.74%
Purchase of Finished goods
212.30
1,244.57
-1,032.27
-82.94%
(Increase) / Decrease In Stocks
77.30
-93.01
170.31
183.11%
Employee Cost
1,677.30
1,989.92
-312.62
-15.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,109.20
2,225.77
-1,116.57
-50.17%
Total Expenditure (Excl Depreciation)
4,477.40
6,838.33
-2,360.93
-34.52%
Operating Profit (PBDIT) excl Other Income
828.30
2,361.60
-1,533.30
-64.93%
Other Income
44.90
287.35
-242.45
-84.37%
Operating Profit (PBDIT)
873.20
2,648.95
-1,775.75
-67.04%
Interest
187.60
238.94
-51.34
-21.49%
Exceptional Items
362.80
0.00
362.80
Gross Profit (PBDT)
1,048.40
2,410.01
-1,361.61
-56.50%
Depreciation
273.40
405.66
-132.26
-32.60%
Profit Before Tax
774.70
2,007.79
-1,233.09
-61.42%
Tax
89.60
427.80
-338.20
-79.06%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
685.40
1,576.55
-891.15
-56.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
685.40
1,576.55
-891.15
-56.53%
Share in Profit of Associates
-0.40
9.92
-10.32
-104.03%
Minority Interest
0.40
-7.70
8.10
105.19%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
685.80
1,570.19
-884.39
-56.32%
Equity Capital
15.80
40.06
-24.26
-60.56%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
19.76%
26.20%
0.00
-6.44%
PAT Margin
12.92%
17.14%
0.00
-4.22%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 5,305.70 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 7.31% vs 7.40% in Dec 2023
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 685.80 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 405.38% vs 268.15% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 828.30 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 31.60% vs 12.99% in Dec 2023
Nine Monthly - Interest
Interest 187.60 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -5.87% vs 50.26% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.61%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
